Capricor Therapeutics Inc CAPR

$9.37 +5.28% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-24 View →
10-Q 10-Q 2026-08-14 View →
8-K 8-K 2026-08-13 View →
8-K 8-K 2026-07-30 View →
8-K 8-K 2026-07-29 View →
8-K 8-K 2026-07-14 View →
4 Insider transaction 2026-06-29 View →
4 Insider transaction 2026-06-29 View →
8-K 8-K 2026-06-26 View →
4 Insider transaction 2026-06-24 View →
4 Insider transaction 2026-06-24 View →
8-K 8-K 2026-06-08 View →
4 Insider transaction 2026-05-28 View →
4 Insider transaction 2026-05-19 View →
4 Insider transaction 2026-05-14 View →
10-Q 10-Q 2026-05-13 View →
8-K 8-K 2026-05-12 View →
8-K 8-K 2026-05-07 View →
4 Insider transaction 2026-05-04 View →
4 Insider transaction 2026-05-04 View →
DEF 14A DEF 14A 2026-04-10 View →
4 Insider transaction 2026-04-03 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-03-27 View →
10-K 10-K 2026-03-17 View →
8-K 8-K 2026-03-12 View →
8-K 8-K 2026-03-10 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2026-01-07 View →
4 Insider transaction 2025-12-23 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$9.37
Market Cap
$517.44 million
52-Week Range
$2.96 – $40.37
Average Volume
8.68 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.